1Tsang A,Hausenloy D J,Mocanu M M,et al.Postconditioning:a form of"modified reperfusion"protects themyocardium by activating the phosphatidylinositol 3-kinase-Akt pathway[J].Cire Res,2004,95(3):230-232.
2Hausenloy D J,Yellon D M.Preconditioning and postconditioning:new strategies for cardioprotection[J].Diabetes Obes Metab,2008,10(6):451-459.
3Hausenloy D J,Yellon D M.Preconditioning and postconditioning:United at reperfusion[J].Pharmacol Ther,2007,116(2):173-191.
4Murry C E,Downey R B,Reimer K A.Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium[J].Cirulation,1986,74:1124-1136.
5Kloner R A,Bolli R,Marban E.Medical and cellular implications of stunning,hibernation,and preconditioning:an NHLBI workshop,1998,97(18):1848-1867.
6Ferdinandy P,Schulz R,Baxter G F.Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury,preconditioning,and postconditioning[J].Pharmacol Rev,2007,59:418-458.
7Cohn M V.Protein kinase C phys a central role in the protection of ischemic and pharmacologic preconditioning[J].Mol Cell Cardiol,1994,26(7):S41.
8Zhao Z Q,Conrera J S,Halkos M E,et a1.Inhibition 0f myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemlc preconditioning[J].Am J Physiol Heart Cir Physiol,2003,285(2):H579-H588.
9Vinten Johansen J.Postconditioning:amechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion[J].Heart Fail Rev,2007,12:235-244.
10Burley D S,Baxter G F.Pharmacological targets revealed by myocardial postconditioning[J].Curr Opin Pharmacol,2009,9(2):177-188.
2Murry CE,Jennings RB,Reimer KA.Preconditioning with ischemia: a delay lethal cell injury in ischemic myocardium. Circulation . 1986
3Walsh SR,Tang TY,Kullar P. Ischaemic preconditioning during cardiac surgery:systematic review and meta-analysis of perioperative outcomes in randomized clinical trials[J].European Journal of Cardio-Thoracic Surgery,2008,(05):985-994.doi:10.1016/j.ejcts.2008.07.062.
4Zhao ZQ,Corvera JS,Halkos ME. Inhibition of myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemic preconditioning[J].American Journal of Physiology-Heart and Circulatory Physiology,2003,(02):784-785.
5SchulzeCJ, WangW, KumariR, etal. Imbalance between tissue inhibitor of metallopreteinas -4 and matrix metal - lopreteinases during acute myocardial correction of myocardial ischemia - reperfusion injury [ J ] Circulation, 2003, 107 (19) : 2487-2492.
6Burley D S, Baxter G F. Pharmacological targets revealed by myocardi- al postconditioning[ J]. Curr Opin Pharmacol,2009,9(2) :177 - 188.
7Tissier R, Waintraub X, Couvreur N, et al. Pharmacological post condi- tioning with the phytoestrogen genistein [ J ] . J Mol Cell Cardio1,2007, 42( 1 ) :79 -87.
